The next few years promise a sea change for what may be the most important aspect of the artificial intelligence industry.

At a time when insurers are backing away from coverage for weight loss medications, President Trump has offered a lifeline ...

The weak growth occurred despite gross payment volume (GPV) for its Square platform increasing 12% compared to the prior-year ...

Block shares fell nearly 8% Friday after weak third-quarter earnings fell short of Wall Street expectations and showed slowing profit growth for the company's Square service. Here is how the company ...

GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the ...